Skip to main content

Year: 2024

Nevada Lithium to Commence Trading on TSX Venture Exchange Effective December 31, 2024

VANCOUVER, British Columbia, Dec. 27, 2024 (GLOBE NEWSWIRE) — Nevada Lithium Resources Inc. (“Nevada Lithium” or the “Company“) (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) is pleased to announce that the TSX Venture Exchange (the “TSXV”) has approved the Company’s application to list its common shares (the “Shares”) on the TSXV. Effective at the market open on December 31, 2024, the Shares will commence trading on the TSXV. The Company’s ticker symbol “NVLH” will remain unchanged, and shareholders will not be required to take any action in connection with the Company’s listing on the TSXV. In connection with the listing of the Shares on the TSXV, the Company has submitted a request to voluntarily delist the Shares from the Canadian Securities Exchange (the “CSE”). The CSE delisting is expected to be effective at...

Continue reading

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

SHENZHEN, China, Dec. 27, 2024 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”) today announced that it has received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) dated December 24, 2024, indicating that the Company is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as the bid price of the Company’s Class A ordinary shares had closed below US$1 per share for the last 30 consecutive business days from November 11 through December 23, 2024. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a compliance period of 180 calendar days until June 23, 2025 to regain compliance. The Company will regain compliance if, at any time during this 180-day period, the closing bid price...

Continue reading

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and reduction in the total number of authorized shares of its common stock from 200,000,000 to 16,666,667 will be effective as of 5:00 p.m. Eastern Time on Monday, December 30, 2024. The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Tuesday, December 31, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “CARA” with the new CUSIP number, 140755 208. The reverse stock split is part of the Company’s plan to regain compliance with the minimum bid price requirement...

Continue reading

Correction: Invesco Ltd: Form 8.3 – Aviva PLC; Public dealing disclosure

Amendment: This is an amendment to the form submitted on 24.12.2024 at 12:07. Amendment has been done in Section 2(a) & 3(a) of the form. FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Aviva PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date...

Continue reading

Correction: Correction: Invesco Ltd: Form 8.3 – International Paper Company; Public dealing disclosure

Amendment: This is an amendment to the form submitted on 24.12.2024 at 09:19. Amendment has been done in Section 2(a) & 3(a) of the form. FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree International Paper Company  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify...

Continue reading

Information about shares issued by INVL Baltic Real Estate and votes granted

Considering that during the shares buy-back process of INVL Baltic Real Estate (hereinafter – the Company), the Company acquired 61,721 shares for EUR 166,646.70 from the Company’s shareholders for which they were paid on 24 December 2024, the Company announces the data on shares issued by the Company as of 24 December 2024:Type of shares Number of shares and total voting rights granted by the issued shares, units Number of votes for the quorum of the General Shareholders Meeting, units Nominal value, EUR Total nominal Value and authorised capital, EUR Portion of the authorised capital, %Ordinary registered shares 8,061,414 7,953,934 1.45 11,689,050.30 100The person authorized to provide additional information: Real Estate Fund Manager of Management Company Vytautas Bakšinskas E-mail vy...

Continue reading

NKT awarded two high-voltage projects under existing framework agreement with TenneT

Company Announcement 27 December 2024 Announcement No. 38 NKT awarded two high-voltage projects under existing framework agreement with TenneT NKT has been awarded two turnkey projects in Germany under the existing multi-year framework agreement with TenneT. The projects are part of TenneT’s 2GW Program, which is considered one of the most ambitious infrastructure projects in the energy transition of Europe. TenneT, the Dutch-German transmission system operator, has selected NKT to provide 525 kV XLPE high-voltage direct current (HVDC) on- and offshore power cable systems for two projects under the existing framework agreement, which was announced in Company Announcement no. 14 of 5 May 2023. – We are thrilled to once again be selected as a key partner for TenneT’s ambitious 2GW Program. This confirms our strong partnership and NKT’s...

Continue reading

Aalberts N.V.: Aalberts strengthens heat treatment footprint in North America

Utrecht, 27 December 2024 Aalberts N.V. has reached an agreement to acquire 100% of the shares of Paulo Products Company (Paulo), operating five facilities in the USA and one in Mexico, generating an annual revenue of approximately USD 105 million with 522 employees. Paulo is a provider of industrial heat treatment and related services that are critical to achieving strength, hardness, and other metallurgical properties required in various industrial applications. It is the largest privately owned thermal processing platform in North America providing solutions including heat treatment, brazing and metal finishing. Paulo serves attractive end markets like automotive, aerospace, defence and power generation. In line with our ‘thrive 2030’ strategy, this acquisition will strengthen our geographical footprint in the USA. By combining Paulo’s...

Continue reading

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx’s VYVGART® and VYVDURA portfolio approved in Japan for three indications – first country globally with access across three indications December 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). VYVDURA is approved for CIDP as a once weekly 30-to-90 second subcutaneous injection, which can be self-administered at home, and is the first and only neonatal Fc receptor (FcRn) blocker approved for the treatment...

Continue reading

Himax to Showcase Industry-Leading 400K Nits Ultra-Luminous Color Sequential Front-lit LCoS Microdisplay at CES 2025

Revolutionizing See-Through AR Glasses with Unmatched Brightness and a Compact, Outdoor-Ready Design TAINAN, Taiwan, Dec. 27, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and other semiconductors, today announced it will present its next-generation, proprietary ultra luminous 400K nit Color Sequential Front-lit LCoS Microdisplay solution at CES 2025, the largest consumer electronics show in Las Vegas, U.S.A. from January 7 – 10, 2025. The unparalleled brightness of the LCoS solution reaffirms Himax’s market leadership in LCoS and its steadfast commitment to advancing AR applications, catering to the critical demands of leading tech innovators in AR technology. Himax’s proprietary Color Sequential Front-lit LCoS Microdisplay sets...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.